CLNN: Clene Inc. Stock

by  •  • Comments Off on CLNN: Clene Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 32.00
Enterprise Value ($M) 35.17
Book Value ($M) -4.12
Book Value / Share -0.52
Price / Book -7.76
NCAV ($M) -16.00
NCAV / Share -2.00
Price / NCAV -2.00

Profitability (mra)
Return on Invested Capital (ROIC) -1.92
Return on Assets (ROA) -0.60
Return on Equity (ROE) -1.68

Liquidity (mrq)
Quick Ratio 0.82
Current Ratio 0.83

Balance Sheet (mrq) ($M)
Current Assets 19.70
Assets 31.57
Liabilities 35.69
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G Armistice Capital, Llc 8.77
11-12 13G/A Mosca Alison 11.60
02-14 13G AWM Investment Company, Inc. 9.20
02-14 13G/A Citadel Advisors Llc 4.50
02-13 13G/A Vivo Opportunity Fund Holdings, L.P. 7.00 -29.53

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT UNDER

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-22 19,719 67,617 29.16
2024-11-21 26,559 127,573 20.82
2024-11-20 13,420 126,736 10.59
2024-11-19 11,928 47,554 25.08

(click for more detail)

Similar Companies
CING – Cingulate Inc. CKPT – Checkpoint Therapeutics, Inc.
CLDX – Celldex Therapeutics, Inc. CLRB – Cellectar Biosciences, Inc.
CMPX – Compass Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io